RemeGen Co Ltd
HKEX:9995
Balance Sheet
Balance Sheet Decomposition
RemeGen Co Ltd
Current Assets | 2.2B |
Cash & Short-Term Investments | 726.6m |
Receivables | 473.5m |
Other Current Assets | 1B |
Non-Current Assets | 3.3B |
Long-Term Investments | 98.2m |
PP&E | 3B |
Intangibles | 143.8m |
Other Non-Current Assets | 20.8m |
Current Liabilities | 1.1B |
Accounts Payable | 125.3m |
Accrued Liabilities | 224.2m |
Short-Term Debt | 301.4m |
Other Current Liabilities | 477.1m |
Non-Current Liabilities | 962.9m |
Long-Term Debt | 915.3m |
Other Non-Current Liabilities | 47.6m |
Balance Sheet
RemeGen Co Ltd
Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|
Assets | |||||||
Cash & Cash Equivalents |
5
|
35
|
2 769
|
1 757
|
25
|
727
|
|
Cash |
0
|
0
|
0
|
0
|
23
|
726
|
|
Cash Equivalents |
5
|
35
|
2 769
|
1 757
|
2
|
0
|
|
Total Receivables |
15
|
18
|
36
|
36
|
303
|
473
|
|
Accounts Receivables |
11
|
1
|
0
|
7
|
202
|
298
|
|
Other Receivables |
4
|
17
|
36
|
29
|
101
|
176
|
|
Inventory |
30
|
31
|
66
|
280
|
523
|
742
|
|
Other Current Assets |
16
|
54
|
107
|
227
|
317
|
287
|
|
Total Current Assets |
65
|
138
|
2 977
|
2 300
|
3 212
|
2 229
|
|
PP&E Net |
398
|
471
|
941
|
1 727
|
2 663
|
3 036
|
|
PP&E Gross |
398
|
471
|
941
|
1 727
|
2 663
|
3 036
|
|
Accumulated Depreciation |
63
|
103
|
150
|
214
|
469
|
699
|
|
Intangible Assets |
3
|
2
|
5
|
13
|
56
|
144
|
|
Note Receivable |
31
|
48
|
61
|
55
|
0
|
0
|
|
Long-Term Investments |
10
|
11
|
13
|
12
|
81
|
98
|
|
Other Long-Term Assets |
24
|
20
|
121
|
53
|
9
|
21
|
|
Total Assets |
531
N/A
|
689
+30%
|
4 118
+497%
|
4 159
+1%
|
6 021
+45%
|
5 528
-8%
|
|
Liabilities | |||||||
Accounts Payable |
17
|
68
|
63
|
159
|
109
|
125
|
|
Accrued Liabilities |
16
|
29
|
59
|
114
|
138
|
224
|
|
Short-Term Debt |
0
|
60
|
108
|
0
|
122
|
301
|
|
Current Portion of Long-Term Debt |
1
|
2
|
43
|
53
|
60
|
60
|
|
Other Current Liabilities |
964
|
698
|
159
|
290
|
448
|
417
|
|
Total Current Liabilities |
997
|
857
|
431
|
616
|
877
|
1 128
|
|
Long-Term Debt |
3
|
4
|
47
|
50
|
105
|
915
|
|
Deferred Income Tax |
0
|
0
|
1
|
0
|
0
|
2
|
|
Other Liabilities |
29
|
61
|
45
|
46
|
59
|
46
|
|
Total Liabilities |
1 029
N/A
|
921
-10%
|
523
-43%
|
713
+36%
|
1 041
+46%
|
2 091
+101%
|
|
Equity | |||||||
Common Stock |
0
|
0
|
490
|
490
|
544
|
544
|
|
Retained Earnings |
568
|
402
|
605
|
310
|
1 342
|
2 854
|
|
Additional Paid In Capital |
70
|
169
|
3 709
|
3 709
|
6 233
|
6 238
|
|
Unrealized Security Profit/Loss |
0
|
1
|
1
|
0
|
1
|
58
|
|
Treasury Stock |
0
|
0
|
0
|
449
|
463
|
440
|
|
Other Equity |
0
|
0
|
0
|
6
|
9
|
7
|
|
Total Equity |
498
N/A
|
232
+53%
|
3 595
N/A
|
3 446
-4%
|
4 980
+45%
|
3 437
-31%
|
|
Total Liabilities & Equity |
531
N/A
|
689
+30%
|
4 118
+497%
|
4 159
+1%
|
6 021
+45%
|
5 528
-8%
|
|
Shares Outstanding | |||||||
Common Shares Outstanding |
478
|
478
|
490
|
490
|
539
|
538
|